There are currently ten companies located at GatewayUCC. Among the successful spin-outs to emerge from the facility so far is location analytics provider Thinksmart Technologies, which was acquired by US multinational Cisco Systems last year.

Another spin-out is Solvotrin Therapeutics, which specialises in creating new protected drugs for the treatment of rare diseases in the area of cardiovascular and cancer prevention.

Innovative new ventures located in GatewayUCC come from a wide array of sectors from ICT, to biotech/medtech and food health. 

In addition a number of companies have already incubated and graduated from GatewayUCC with success stories such as Open Innovation Partners and Energywatch continuing to expand with their UCC licensed technologies into bigger facilities in the business community.

GatewayUCC manager Myriam Cronin highlighted the success of Atlantia Food Clinical Trials and Luxcel BioSciences as examples of companies that anticipate creating further jobs in the months ahead.

“The GatewayUCC incubation facility provides a dynamic and modern infrastructure that promotes interaction with both academic and industrial partners, which is of great benefit to us at this stage of our development,” Dr Sally Cudmore, CEO, Atlantia Food Clinical Trials.

“Access to a world-leading research institute in the food for health space, the Alimentary Pharmabiotic Centre (APC), is a key success factor for our start-up venture.”

GatewayUCC client companies can access such services as wet labs, bio-science units and Tyndall labs, and avail of support and fully serviced offices while they grow and expand.